Treatment of advanced disease in NOD mice by immunomodulation and expansion of B-cell mass: a combined approach

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Exp Clin Endocrinol Diabetes 1997; 105: 72-73
DOI: 10.1055/s-0029-1211896

Session 8: Therapeutic approach and pharmacological considerations for the treatment of spontaneous IDDM and NIDDM

David J. Gross¹ , Lola Weiss² , Israel Reibstein² , Joop van den Brand³ , Hiroshi Okamoto⁴ , Anne Clark³ , Shimon Slavin²

¹Departments of Endocrinology & Metabolism, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
²Bone Marrow Transplantation and Cancer Immunobiology Laboratory, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
³Oxford Diabetes Research Laboratories, Radcliffe Infirmary, Oxford, OX2 6E, United Kingdom
⁴Department of Biochemistry, Tohoku University School of Medicine, Sendai , Japan

Further Information

Publication Date:
15 July 2009 (online)

>